HP

Henry Peter Dsouza

Active Director Director DIN 06787213
DIN 06787213 First appointment Feb 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2014
Shareholding value •••• Premium profile

About Henry Peter Dsouza

Data last updated:

Henry Peter Dsouza is a Director at Lanolin Pharma & Chemicals Private Limited (since 2014). The company operates in Pharma. Lanolin Pharma & Chemicals Private Limited reported revenue of ₹1.01 Cr (FY 2022).

DIN 06787213
Primary Designation Director
Industry Pharma
First Appointment 05 Feb 2014
Oldest Company Age 12 yrs
Largest company Lanolin Pharma & Chemicals Private Limited · ₹1.01 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Feb 20142014₹1.01 Cr (FY 2022)Active

Board colleagues of Henry Peter Dsouza

NameDINCompanyDesignation
Priti Henry D'souza07358069Lanolin Pharma & Chemicals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Lanolin Pharma & Chemicals Private Limited
Premium access

Shareholding and investment profile for Henry Peter Dsouza

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Henry Peter Dsouza

Henry Peter Dsouza currently holds 1 directorship: Lanolin Pharma & Chemicals Private Limited (Director, since 05 Feb 2014, revenue ₹1.01 Cr (FY 2022)).

Henry Peter Dsouza was first appointed on 05 Feb 2014 as Director at Lanolin Pharma & Chemicals Private Limited.

The current boards of Henry Peter Dsouza's companies include Priti Henry D'souza (Lanolin Pharma & Chemicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available